FemtoDx Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2M
- Investors
-
4
FemtoDx General Information
Description
Developer of monitoring markers designed to monitor heart failure and liver injury at home. The company offers clinically validated biomarker panels with multiplexed diagnostic capability at clinically relevant levels and reduced cost and processing time, enabling heart patients and individuals with liver conditions to detect disease progression from home with timely clinical insight.
Contact Information
Website
www.femtodx.comCorporate Office
- 1999n Avenue Of The Stars
- Suite 1100
- Los Angeless, CA 90067
- United States
Corporate Office
- 1999n Avenue Of The Stars
- Suite 1100
- Los Angeless, CA 90067
- United States
FemtoDx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 03-Feb-2023 | $2M | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series A2) | 16-Sep-2021 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 09-Jul-2019 | $12M | $12M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Jan-2019 | Completed | Product In Beta Test |
FemtoDx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
FemtoDx Patents
FemtoDx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230149928-A1 | Sensor-based systems and methods for diagnostic and field use detection of nucleic acids | Pending | 03-Apr-2020 | ||
| WO-2021202991-A1 | Sensor-based systems and methods for diagnostic and field use detection of nucleic acids | Inactive | 03-Apr-2020 | ||
| US-20210263025-A1 | Micro-separation for multiplexing | Pending | 20-Feb-2020 | ||
| WO-2021168245-A1 | Micro-separation for multiplexing | Inactive | 20-Feb-2020 | ||
| EP-4096829-A1 | Fluidic stack and reference electrode for sample collection and analysis and related methods | Inactive | 27-Jan-2020 | B01L3/502753 |
FemtoDx Signals
FemtoDx Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Canon Medical Systems | Corporation | Minority | ||
| K2X | Venture Capital | Minority | ||
| Next Orbit Ventures | Growth/Expansion | Minority | ||
| Magnify | Accelerator/Incubator |
FemtoDx FAQs
-
When was FemtoDx founded?
FemtoDx was founded in 2014.
-
Where is FemtoDx headquartered?
FemtoDx is headquartered in Los Angeless, CA.
-
What is the size of FemtoDx?
FemtoDx has 9 total employees.
-
What industry is FemtoDx in?
FemtoDx’s primary industry is Monitoring Equipment.
-
Is FemtoDx a private or public company?
FemtoDx is a Private company.
-
What is FemtoDx’s current revenue?
The current revenue for FemtoDx is .
-
How much funding has FemtoDx raised over time?
FemtoDx has raised $17.5M.
-
Who are FemtoDx’s investors?
Canon Medical Systems, K2X, Next Orbit Ventures, and Magnify have invested in FemtoDx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process